Fig. 3. Target population for vaccines in the 21st century by Rappuoli et al. [25]. (A) The most important vaccines for each age group are reported. (B)

Slides:



Advertisements
Similar presentations
DISEASE AND PANDEMICS Brijesh Patel.
Advertisements

CHAPTER 7 Infectious Diseases from a Global Perspective.
MICROBIOLOGY PRESENTATION BY Momen ali khan. Staphylococcus Streptococcus Enterococcus faecalis.
Antimicrobial Stewardship Program 2 nd Quarter May 19, 2016 Jill Hanson, WHA DeAnn Richards, MetaStar.
Operations  Started research operations (10 FTEs) in September 2011  Redx Anti-Infectives launched in Alderley Park in April 2013  Currently 55 scientists.
Food Science & Nutrition
STUKYI_ Antibacterial & Deodorization Spray
Antimicrobial Resistance at GLA
Fig. 2.Ratio of patents for influenza vaccine technology according to each animal species in six major intellectual property offices. United States leads.
Fig. 2.The intestinal secretory IgA (sIgA) antibody response was measured in chickens against the outer membrane protein for 7 weeks PPI. Antibody levels.
Alison Keyser Metobo, MPH +
Resistenzepidemiologie 2015
RENAL TRANSPLANTATION IN AN INTENSIVE CARE UNIT:
Agents of nosocomial (hospital-acquired) infections
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
Recommended Timeline for Influenza Vaccinations
lecture notes second med students- Vaccination
HOSPITAL INFECTIONS Norazli Ghadin.
CSI 101 Skills Lab 3 Universal Precautions and
Discuss formal report assignment Get acquainted with the library
Summary of WHO PPL, CDC, and ESKAPE pathogen lists
Chapter 20 Communicable and Infectious Disease
lecture notes second med students- Vaccination
Product Herbasafe Hand Soap Herbasafe Sanitizer Herbasafe Lotion
KEY CONCEPT Some viral diseases can be prevented with vaccines.
M.A.C. Broeren, Y. Maas, E. Retera, N.L.A. Arents 
اچ ای وی ايدز. اچ ای وی ايدز سند رم نقص ايمنی اكتسا بی سند رم نقص ايمنی اكتسا بی AIDS Acquired Immuno Deficiency Syndrome.
PCP: management of co-infection
Pneumococcal infection in adults: burden of disease
Use of a multiplex PCR-based reverse line blot (mPCR/RLB) hybridisation assay for the rapid identification of bacterial pathogens  Y. Wang, F. Kong, G.L.
Antibiotics AMANY NIAZY
Gram Negative Bacteria
Fig. 1. Chemical-repeating unit structures of group B streptococcus (GBS) capsular polysaccharides (CPSs). CPSs are classified in three class depending.
Does your patient have CHF?
Purple urine bag syndrome in a hemodialysis patient
Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections 
Hospital Acquired Infections
Empirical antibiotic treatment algorithm for hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP). Empirical antibiotic treatment algorithm.
Summary of WHO PPL, CDC, and ESKAPE pathogen lists
Characterizing non-linear effects of hospitalisation duration on antimicrobial resistance in respiratory isolates: an analysis of a prospective nationwide.
Appropriate vs. inappropriate antimicrobial therapy
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
Training XX Hospital.
Pharmacodynamics of doxycycline
PCP: management of co-infection
ئەيدىز كېسىلى (AIDS) مەمەتئىمىن دوكتۇر.
5 TH GENERATION CEPHALOSPORINS DAWOOD ALYAMI 1. Contents What are Cephalosporins History of Cephalosporins Mechanism of action Generation of Cephalosporins.
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes  S. Ladhani,
Implementation of European standards of care for cystic fibrosis ��� Control and treatment of infection  J.S. Elborn, M. Hodson, C. Bertram  Journal of.
Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae.
K.J. Psoter, A.J. De Roos, J. Wakefield, J. Mayer, M. Rosenfeld 
M. C. Alanin, K. G. Nielsen, C. von Buchwald, M. Skov, K. Aanaes, N
J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. H. T. Wagenvoort, J. W
P. Kaltsas, S. Want, J. Cohen  Clinical Microbiology and Infection 
Antibiotics AMANY NIAZY
Illustrative Performance Improvement Targets
Benefit of surveillance cultures at NICU
Surveillance of Healthcare-associated Infections in NI
Point prevalence survey (PPS) of healthcare associated infections (HAI) & antimicrobial use (AMU) in acute care Mark McConaghy, Dr Muhammad Sartaj,
Target disease and target populations for 21st century vaccine developmentIncluded in the list are the agents of infectious diseases for which vaccines.
Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory 
Antibiotic overconsumption and resistance in Turkey
Receiver operating characteristic (ROC) curves (area under the curve (AUC) (95% CI)) for FACED (forced expiratory volume in 1 s, age, chronic colonisation.
Number of ventilator-associated pneumonia (VAP) patients with newly isolated micro-organisms from endotracheal aspirates after initiation of antibiotic.
Weekly pneumococcal community-acquired pneumonia incidence rates over 5 years, with delineated school holiday periods by year. a) Year 1 (September 2008–2009).
Distribution of patients in the first- or second-year follow-up according to the number of acute exacerbations of chronic obstructive pulmonary disease.
Effects of AG on the colon histology score in the acute DSS colitis model. Effects of AG on the colon histology score in the acute DSS colitis model. Ten.
Bacterial/Viral Meningitis & Haemophilus influenzae Trends in Ireland
Influenza vaccine enhances NK cell function through IFN-α.
Prevalence of acute myocardial infarction (AMI) or other cardiovascular events (CVEs) according to a) Pneumonia Severity Index (PSI) risk classes and b)
Presentation transcript:

Fig. 3. Target population for vaccines in the 21st century by Rappuoli et al. [25]. (A) The most important vaccines for each age group are reported. (B) Special target groups for vaccination in the 21st century. The most important vaccines for each target group are reported. The lists of vaccines reported are indicative and are not intended to be exhaustive. C. difficile, Clostridium difficile; E. coli, Escherichia coli; EV71, enterovirus 71; H. influenzae, Haemophilus influenzae; K. pneumoniae, Klebsiella pneumoniae; P. aeruginosa, Pseudomonas aeruginosa; S. aureus, Staphylococcus aureus; AIDS, acquired immune deficiency syndrome; SARS, severe acute respiratory syndrome. Fig. 3. Target population for vaccines in the 21st century by Rappuoli et al. [25]. (A) The most important vaccines for each age group are reported. (B) Special target groups for vaccination in the 21st century. The most important vaccines for each target group are reported. The lists of vaccines reported are indicative and are not intended to be exhaustive. C. difficile, Clostridium . . . Clin Exp Vaccine Res. 2015 Jan;4(1):46-53. http://dx.doi.org/10.7774/cevr.2015.4.1.46